Zhuhai Baolian Asset Management Co., Ltd, a subsidiary of China’s state-owned Gree Real Estate, is picking up an 18.63 per cent stake in in-vitro diagnostics firm Shanghai Kehua Bio-engineering Co., Ltd (KHB) for 1.7 billion yuan ($240 million), per a company statement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
